Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

294 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study.
Latry P, Molimard M, Dedieu B, Couffinhal T, Bégaud B, Martin-Latry K. Latry P, et al. BMC Cardiovasc Disord. 2011 Jul 26;11:46. doi: 10.1186/1471-2261-11-46. BMC Cardiovasc Disord. 2011. PMID: 21791073 Free PMC article.
[Some questions about statins].
Dangoumau J, Haramburu F, Bégaud B. Dangoumau J, et al. Therapie. 2003 Jan-Feb;58(1):91-5. doi: 10.2515/therapie:2003013. Therapie. 2003. PMID: 12822206 Review. French.
Hepatitis B vaccination and first central nervous system demyelinating event: a case-control study.
Touzé E, Fourrier A, Rue-Fenouche C, Rondé-Oustau V, Jeantaud I, Bégaud B, Alpérovitch A. Touzé E, et al. Neuroepidemiology. 2002 Jul-Aug;21(4):180-6. doi: 10.1159/000059520. Neuroepidemiology. 2002. PMID: 12065880 Clinical Trial.
OBJECTIVE: To investigate the relationship between hepatitis B (HB) vaccination and a first central nervous system (CNS) demyelinating event in adults. ...
OBJECTIVE: To investigate the relationship between hepatitis B (HB) vaccination and a first central nervous system (CNS) demyelinatin …
Benzodiazepine use and risk of dementia: prospective population based study.
Billioti de Gage S, Bégaud B, Bazin F, Verdoux H, Dartigues JF, Pérès K, Kurth T, Pariente A. Billioti de Gage S, et al. BMJ. 2012 Sep 27;345:e6231. doi: 10.1136/bmj.e6231. BMJ. 2012. PMID: 23045258 Free PMC article.
Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study.
Depont F, Fourrier A, Merlière Y, Droz C, Amouretti M, Bégaud B, Bénichou J, Moride Y, Velo GP, Sturkenboom M, Blin P, Moore N; CADEUS Team. Depont F, et al. Pharmacoepidemiol Drug Saf. 2007 Aug;16(8):891-900. doi: 10.1002/pds.1388. Pharmacoepidemiol Drug Saf. 2007. PMID: 17351983
Are generic drugs really inferior medicines?
Moore N, Berdaï D, Bégaud B. Moore N, et al. Clin Pharmacol Ther. 2010 Sep;88(3):302-4. doi: 10.1038/clpt.2010.168. Clin Pharmacol Ther. 2010. PMID: 20725079
Is reporting rate a good predictor of risks associated with drugs?
Pierfitte C, Bégaud B, Lagnaoui R, Moore ND. Pierfitte C, et al. Br J Clin Pharmacol. 1999 Mar;47(3):329-31. doi: 10.1046/j.1365-2125.1999.00881.x. Br J Clin Pharmacol. 1999. PMID: 10215758 Free PMC article.
When patients report diseases that prescribers seem unaware of: discordance between patient and physician reporting of risk-related previous history in NSAID users from the CADEUS study.
Fourrier-Réglat A, Lacoin L, Pariente A, Lassalle R, Robinson P, Droz-Perroteau C, Bégaud B, Blin P, Moore ND. Fourrier-Réglat A, et al. Clin Pharmacol Ther. 2010 Nov;88(5):668-75. doi: 10.1038/clpt.2010.166. Epub 2010 Sep 22. Clin Pharmacol Ther. 2010. PMID: 20861835
Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use.
Fourrier A, Letenneur L, Dartigues JF, Moore N, Bégaud B. Fourrier A, et al. Eur J Clin Pharmacol. 2001 Aug;57(5):419-25. doi: 10.1007/s002280100326. Eur J Clin Pharmacol. 2001. PMID: 11599660
294 results
Jump to page
Feedback